Brean Murray Carret & Co. Starts Cubist Pharmaceuticals (CBST) at Hold; Waiting Until Next Growth Driver

Brean Murray Carret & Co. initiates coverage on Cubist Pharmaceuticals (NASDAQ: CBST) with a Hold.

Analyst, Brian Skorney, said, "We believe the company has several shots on goal in late stage clinical development that could result in significant upside, but we believe lingering questions on the market opportunities, assuming clinical success, are years from being answered."

For an analyst ratings summary and ratings history on Cubist Pharmaceuticals click here. For more ratings news on Cubist Pharmaceuticals click here.

Shares of Cubist Pharmaceuticals closed at $43.77 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Deutsche Bank Starts Ardagh Metal Packaging S.A. (AMBP) at Hold
• B.Riley Starts Alpha Cognition Inc (ACOG) at Buy
• Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight